A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers

Inclusion criteria * Healthy female * Surgically sterile or post-menopausal * At least a weight of 50 kg and have a body mass index (BMI) ≤33.0 * Non-smokers or those who smoke 25 cigarettes or less per day Exclusion criteria * Use of certain prescription and over the counter drugs * Having received an investigational drug within 30 days prior to dosing * Donation of plasma or donation or loss of whole blood prior to administration of the study medication * Any clinically significant laboratory tests * Abnormal cardiac function * A positive test for HIV, Hepatitis B or C * A positive alcohol test or drug test * Known allergy to Vatalinib or Omeprazole * Any surgical or medical condition which might significantly alter the absorption, distribution, metabolism and excretion or drugs. Other protocol-defined inclusion/exclusion criteria may apply